Paper · 18239126
Cancer proliferation gene discovery through functional genomics.
Schlabach MR and 16 others. Science, 2008. Cited by 306 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer proliferation gene discovery through functional genomics. Papers, record 18239126. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18239126
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Proliferation | Major topic |
| Colonic Neoplasms | Major topic |
| Genes, Neoplasm | Major topic |
| Genomics | Major topic |
| Cell Line | |
| Cell Line, Tumor | |
| Cell Survival | |
| Gene Library | |
| Genetic Vectors | |
| Genome, Human | |
| Humans | |
| MicroRNAs | |
| Oligonucleotide Array Sequence Analysis | |
| RNA, Small Interfering | |
| Retroviridae |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA013106 | NCI NIH HHS | United States | P01CA013106 | PubMed and NIH | NIH RePORTER |
| F31 NS054507 | NINDS NIH HHS | United States | F31NS054507 | PubMed and NIH | NIH RePORTER |
| T32CA09216 | NCI NIH HHS | United States | T32CA009216 | PubMed and NIH | NIH RePORTER |
| T32 CA009216 | NCI NIH HHS | United States | T32CA009216 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| R01 AG011085 | NIA NIH HHS | United States | R01AG011085 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,042,092 | A large-scale RNAi screen in human cells identifies new components of the p53 pathway. | Nature | 2004 | https://conductscience.org/library/papers/15042092 | PubMed |
| 2 | 14,704,432 | In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. | Science | 2004 | https://conductscience.org/library/papers/14704432 | PubMed |
| 3 | 15,960,972 | A genetic screen for candidate tumor suppressors identifies REST. | Cell | 2005 | https://conductscience.org/library/papers/15960972 | PubMed |
| 4 | 15,960,973 | A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. | Cell | 2005 | https://conductscience.org/library/papers/15960973 | PubMed |
| 5 | 16,200,064 | Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. | Nat Genet | 2005 | https://conductscience.org/library/papers/16200064 | PubMed |
| 6 | 16,572,121 | A loss-of-function RNA interference screen for molecular targets in cancer. | Nature | 2006 | https://conductscience.org/library/papers/16572121 | PubMed |
| 7 | 17,417,629 | A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling. | Nat Cell Biol | 2007 | https://conductscience.org/library/papers/17417629 | PubMed |
| 8 | 17,558,397 | The ubiquitin-specific protease USP28 is required for MYC stability. | Nat Cell Biol | 2007 | https://conductscience.org/library/papers/17558397 | PubMed |
| 9 | 15,042,091 | A resource for large-scale RNA-interference-based screens in mammals. | Nature | 2004 | https://conductscience.org/library/papers/15042091 | PubMed |
| 10 | 17,889,643 | Non-oncogene addiction and the stress phenotype of cancer cells. | Cell | 2007 | https://conductscience.org/library/papers/17889643 | PubMed |
1 to 10 of 17
See all 17 referencesCited by221
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 306 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,402,283 | A pooled Cell Painting CRISPR screening platform enables de novo inference of gene function by self-supervised deep learning. | Nat Commun | 2025 | https://conductscience.org/library/papers/41402283 | PubMed |
| 40,517,166 | Advances in molecular pathology and therapy of non-small cell lung cancer. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40517166 | PubMed |
| 40,028,291 | 3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40028291 | PubMed |
| 39,347,709 | UBA1 dysfunction in VEXAS and cancer. | Oncotarget | 2024 | https://conductscience.org/library/papers/39347709 | PubMed |
| 38,431,617 | RTF2 controls replication repriming and ribonucleotide excision at the replisome. | Nat Commun | 2024 | https://conductscience.org/library/papers/38431617 | PubMed |
| 37,712,571 | Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science. | Cancer Discov | 2023 | https://conductscience.org/library/papers/37712571 | PubMed |
| 37,202,533 | Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer. | Commun Biol | 2023 | https://conductscience.org/library/papers/37202533 | PubMed |
| 34,839,558 | SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma. | Cancer Sci | 2022 | https://conductscience.org/library/papers/34839558 | PubMed |
| 34,529,489 | The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation. | Science | 2021 | https://conductscience.org/library/papers/34529489 | PubMed |
| 34,495,459 | Distinct genetic landscape and a low response to doxorubicin in a luminal-A breast cancer cell line of Pakistani origin. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/34495459 | PubMed |
1 to 10 of 221
See all 221 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18239126
GET https://conductscience.org/api/papers/v1/18239126/cited_by?page=2